Abcam PLC operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abcam PLC with three other
pharmaceutical manufacturers in Europe:
Vectura Group PLC
sales of £72.00 million [US$87.70 million]
of which 100%
was Pharmaceutical Prod),
Dottikon ES Holding AG
(121.43 million Swiss Francs [US$120.35 million]
of which 90%
was Pharma Products), and
Dechra Pharmaceuticals PLC
(£247.56 million [US$301.54 million]
of which 76%
was European Pharmaceuticals).
Abcam PLC reported sales of £171.67 million (US$209.10 million)
June of 2016.
increase of 19.2%
versus 2015, when the company's sales were £144.03 million.
Sales at Abcam PLC have increased during each of the previous five years
(and since 2011, sales have increased a total of 106%).